An interim analysis refers to a planned examination of data from an ongoing clinical trial before the study’s completion. It involves evaluating accumulated data at predetermined time points or after a certain number of events have occurred, allowing researchers to assess the trial’s progress, safety, and potential efficacy.
The purpose of an interim analysis is to make informed decisions about the continuation, modification, or early termination of a clinical trial. These analyses can help protect participants from unnecessary risks, optimize resource allocation, and potentially expedite the availability of promising treatments to patients.
Interim analysis is crucial in clinical research as it enables timely decision-making and enhances the ethical conduct of trials. By allowing early assessment of a study’s progress, it helps researchers identify potential safety concerns or unexpected efficacy results that may warrant immediate action.
Furthermore, interim analysis can lead to more efficient use of resources and potentially faster drug development timelines. It provides the opportunity to stop trials early for futility or overwhelming efficacy, thereby saving time and costs while potentially benefiting patients sooner.
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
The FDA and the European Commission are changing the rules of the game simultaneously. The shift is from a single…
Modern nuclear medicine is a high-tech discipline that requires advanced facilities, infrastructure, qualified staff, and know-how. The reliable supply of radionuclides,…
Copyright @ 2026 Axcellant